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Abstract
Background: Endometriosis is a complex disease affecting 10–15% of women at reproductive age.
Very few genes are known to be altered in this pathology. RIP140 protein is an important cofactor
of oestrogen receptor and many other nuclear receptors. Targeting disruption experiments of
nrip1 gene in mice have demonstrated that nuclear receptor interacting protein 1 gene (nrip1), the
gene encoding for rip140 protein, is essential for female fertility. Specifically, mice null for nrip1 gene
are viable, but females are infertile because of complete failure of mature follicles to release oocytes
at ovulation stage. The ovarian phenotype observed in mice devoid of rip140 closely resembles the
luteinized unruptured follicle (LUF) syndrome that is observed in a high proportion of women
affected of endometriosis or idiopathic infertility. Here we present a preliminary work that analyses
the role of NRIP1 gene in humans.
Methods: We have sequenced the complete coding region of NRIP1 gene in 20 unrelated patients
affected by endometriosis. We have performed genetic association studies by using the DNA
variants identified during the sequencing process.
Results: We identified six DNA variants within the coding sequence of NRIP1 gene, and five of
them generated amino acid changes in the protein. We observed that three of twenty sequenced
patients have specific combinations of amino-acid variants within the RIP140 protein that are poorly
represented in the control population (p = 0.006). Moreover, we found that Arg448Gly, a common
polymorphism located within NRIP1 gene, is associated with endometriosis in a case-control study
(59 cases and 141 controls, pallele positivity test = 0.027).
Conclusion: Our results suggest that NRIP1 gene variants, separately or in combinations, might
act as predisposing factors for human endometriosis.
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Background
Endometriosis (Online Mendelian Inheritance in Man
(OMIM) 131200) is a complex disease affecting to 10–
15% of women at reproductive age. The disease consists in
pelvic pain and infertility due to the existence of endome-
trial glands and stroma outside the uterine cavity [1]. Ano-
vulatory cycles and Luteinized Unruptured Follicle
syndrome (LUF) are also evident in a great proportion of
affected women [2,3]. Moreover, recurrent pregnancy
losses, low quality of oocytes and early embryo loss in
women with endometriosis have been suggested [4,5].
Receptor Interacting Protein 140 (RIP140) (Swiss-Prot
P48552) is a high pleiotropic protein that acts as a co-reg-
ulator of multiple members of the nuclear receptor super-
family including oestrogen, progesterone, retinoid acid or
glucocorticoid receptors. Targeting disruption experi-
ments of this function in mice have demonstrated that
nuclear receptor interacting protein 1 (nrip1) gene (GenBank
NM_173440), the gene encoding for rip140 protein, is
essential for female fertility [3]. Specifically, mice null for
nrip1 gene are viable, but females are infertile because of
the complete failure of mature follicles to release oocytes
at ovulation stage [3]. The ovarian phenotype observed in
mice devoid of rip140 closely resembles the LUF syn-
drome that is observed in a high proportion of women
affected by endometriosis or idiopathic infertility [2,3]. In
addition, embryo transfer and ovarian transplantation
experiments in nrip1  knock-out mice indicate slightly
longer pregnancies in nrip1-/- mice and a high rate of foe-
tal and neonatal losses of pups from mothers with nrip1-/
- ovaries [6]. These data suggest that rip140 protein may
have two functions in mice ovaries: i) an essential role in
ovulation; ii) a secondary role in the maintenance of preg-
nancy [3,6]. More recently, a role for nrip1 gene in fat
accumulation has been also proposed [6].
Due to nrip1-/-, female mice have several traits that closely
resemble endometriosis findings; we decided to explore
the role of the human NRIP1  gene (GenBank
NM_003489) in women affected by endometriosis. Direct
molecular analysis of endometriotic tissue specimens
revealed no de novo mutations in 20 affected tissues.
However, different germ-line genetic variants have been
detected during our study. The involvement of these
germline variants with endometriosis is proposed.
Methods
Patients
Endometriosis was defined according to the endometrio-
sis classification system of the American Society for Repro-
ductive Medicine (1996) [7]. All patients included
correspond to stage III or IV of endometriosis. The initial
sequencing project analyzed the complete sequence of
NRIP1 gene in 20 independent DNA samples obtained
from fresh endometriotic tissue derived from peritoneal
implants or endometrioma lesions of 20 unrelated
women with severe endometriosis. We also obtained fresh
blood samples of these patients to test the germ-line or the
somatic nature of the DNA variants detected.
To perform association studies between NRIP1 gene and
human endometriosis, we genotype three groups of indi-
viduals. i) We increase the sample size of the case group
(endometriosis group) three-fold using germ-line DNA
derived from blood of 39 additional women affected by
severe endometriosis (Stage III-IV). Therefore, the sample
size of the endometriosis group for the association studies
conducted was 59 (118 chromosomes). ii) To estimate
population frequencies of mutations or polymorphism
detected, 94 unselected and unrelated controls from the
same geographical region were genotyped in an anony-
mous fashion (188 chromosomes). iii) A "super-control"
group consisted of 47 healthy and fertile women without
any sign or symptom of endometriosis, normal response
to gonadotrophins and conserved ovulation (94 chromo-
somes) was also studied.
The ethnicity background of all probands and controls
was Caucasian (white Europid) minimizing the possibil-
ity of population stratification in our case-control studies.
The referral centers for this study are the Hospital de
Valme (Seville), the Hospital Universitario Virgen de las
Nieves (Granada), and the Hospital Príncipe de Asturias
(Alcalá de Henares, Madrid). Informed consent was
obtained from all patients. The institutional review board
of referral centers has approved our research.
DNA extraction
We obtained 5 ml of peripheral blood from all patients to
isolate germline DNA from leukocytes and about 100 µg
of fresh endometriotic tissue during a programmed lapar-
oscopic intervention of the patients. DNA extraction was
performed according to standard procedures using Nucle-
ospin Blood Kit (Macherey-Nagel) or alternative proto-
cols. To perform Polymerase Chain Reactions (PCRs), we
prepared aliquots of DNA at a concentration of 5 ng/µl.
The rest of the stock was cryopreserved at -20°C.
Mutation analysis
NRIP1 cDNA was first cloned by Cavailles et al. [8]. This
gene is mono-exonic, spans 7,239 base pairs (bp) and is
located at 21q11.2. Genomic sequence containing NRIP1
gene was identified using the blat tool at UCSC Genome
Bioinformatics server http://genome.ucsc.edu/. Informa-
tion concerning any Single Nucleotide Polymorphism
(SNP) or mutation identified was compared with the
UCSC Genome Bioinformatics server and also with the
Single Nucleotide Polymorphism Database (dbSNP) at
the National Centre for Biotechnology InformationJournal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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(NCBI) http://www.ncbi.nlm.nih.gov/. According to
standard mutation nomenclature [9], we employed the
most frequent allele in the first position and the rarer
allele in the last position.
We employed automated DNA sequencing methods to
scan the entire coding sequence of NRIP1 gene in selected
specimens. Overlapping PCRs covering the entire gene
were designed and PCR products were purified and bi-
directionally sequenced using the corresponding pair of
primers (Table 1). Sequencing reactions were performed
using the CEQ Dye Terminator Cycle Sequencing Quick
Start Kit (Beckman Coulter, Inc) according to the manu-
facture's instructions. Fluorograms were analyzed on
CEQ™ 8000 Genetic Analysis System following the manu-
facturer's instructions (Beckman Coulter, Inc).
Genotyping
To verify the DNA variants detected during the sequencing
process and to perform association studies, we employed
Fluorescent Resonance Energy Transfer (FRET) protocols.
We designed and synthesized amplification primers and
fluorescent detection probes for all the DNA variants
identified within the NRIP1  gene. The selected primer
pairs and detection probes are summarized in Tables 1
and 2. Real-time PCR was performed in the LightCycler
system (Roche Applied Science) using reaction conditions
previously published by us [10].
The conditions to obtain optimal melting curves for FRET
analysis and spectrofluorimetric genotypes were 95°C for
0 s, 63°C for 25 s, 45°C for 0 s and 80°C for 0 s (with a
temperature-transfer speed of 20°C/s in each step, except
the last step, in which the speed of temperature transfer
was 0.1°C/s). In the last step, a continuous fluorometric
register was performed fixing the gains of the system at 1,
50, and 50 on channels F1, F2, and F3 respectively. Geno-
type results using real time-PCR are shown in Figure 1a.
To test the specificity of these assays, selected amplicons
of different melting patterns were re-sequenced using an
automated DNA sequencer (Beckman Coulter CEQ
2000XL, data not shown).
Statistical Analysis
To compare allele and genotype frequencies between
patients, control and super-control groups, we performed
conventional chi-square tests with Yates correction or
Fisher exact test using Statcalc (EpiInfo 5.1, Center for Dis-
ease control, Atlanta, GA). For statistical analysis of geno-
type distribution, test for deviation of Hardy-Weinberg
equilibrium or two-point association studies, we
employed six different tests adapted from Sasieni (devia-
tion from Hardy-Weinberg equilibrium, allele frequency
differences test, heterozygous test, homozygous test, allele
positivity test and Armitage's trend test) [11]. These calcu-
lations were performed in the online resource at the Insti-
tute for Human Genetics, Munich, Germany http://
ihg.gsf.de. Significant thresholds for statistical studies
were fixed at p < 0.05.
Results
Looking for somatic mutations within the NRIP1 gene, we
determined the complete coding sequence of the candi-
date gene in 20 selected and unrelated somatic endome-
triotic tissues using bi-directional automated capillary
DNA sequencing. In our primary sequencing project we
Table 1: Amplification primer sequences and PCR product size. NRIP1 is a monoexonic gene. We designed eight overlapping 
amplicons to cover the entire coding sequence of this gene.
PRIMER SEQUENCE 5' → 3' PCR product size (bp)
1F TTCTAGTTCTGCCTCCTTAAC 554
1R ACATTTCTGGCAGTGCATTTC
2F GATCAGGTACTGCCGTTGA 528
2R CGAATCTTCCTGATGTGACT
3F GTGCTATGGTGTTGCATCAAG 572
3R TGCAGGTTATAAGAACTCACTGG
4F CATCATCAAGCAAACTGATGGC 577
4R AGCCCTCAGGGAGTACACAA
5F CTTCAATTGCTACTTGGCCAT 582
5R GTAGTCAACCAACAGGTCCT
6F CTGGAAACACAGATAAACCGATAGG 584
6R TGGCACTTCTAGAATCAAAG
7F AGATAGTTACCTGGCAGATG 572
7R TCCTACTTTCCCTGAGCACT
8F CAGTTGCATGGATAACAGGA 645
8R GTATTGGTTACTGGTGATGJournal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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finished 80,600 bp of DNA. Using our methodology, we
identified six single nucleotide DNA variants within the
coding sequence of the NRIP1 gene in various unrelated
somatic DNA samples. Two of these variants have been
previously identified and they are included in the Single
Nucleotide Polymorphism Database (dbSNP) at the
National Centre for Biotechnology Information (NCBI)
http://www.ncbi.nlm.nih.gov/ (Table 3). Five of these
mutations alter the amino acid coding sequence of
RIP140 protein generating missense mutations (Fig. 1 and
Table 3). Although all mutations were detected in somatic
DNA, direct molecular analyses of the corresponding
blood samples of mutated tissue also contain the same
DNA change. This last result implies that the genetic vari-
ants identified are germ-line and, consequently, somatic
mutations at NRIP1 locus are not commonly involved in
the pathogenesis of human endometriosis.
To evaluate the polygenic role of NRIP1 gene variants in
human endometriosis, we decided to preliminary explore
the allelic frequencies and genotypes of these mutations
in women affected by endometriosis and unselected con-
trols. To conduct genetic association studies, we devel-
oped real-time PCR detection protocols using FRET
probes for each DNA mutation identified at NRIP1 locus.
Using these techniques, we genotyped the mutations in
200 unrelated women (59 endometriosis patients, 94
unselected controls and 47 super-control women). Over-
all, 400 different chromosomes have been scored for each
DNA variant (Table 4).
By analyzing the allelic frequencies of DNA variants
detected in Spanish population, we classified these vari-
ants as common polymorphisms if observed in >1% of
chromosomes in controls (Gly75Gly,  His221Arg,
Ile441Val, Arg448Gly and Ser803Leu) or rare variants if
observed with a frequency <1% of chromosomes in con-
trols (Table 3). In contrast, Val1079Phe allele appears only
in a single patient in heterozygous state and none of 141
controls. This data could suggest its involvement in the
disease. Reinforcing this hypothesis, Val1079Phe is
located close to high-conserved domain of the carboxylic
end of RIP140 protein that interacts with retinoic acid
nuclear receptor (Fig. 1).
Direct inspection of genotypes in patients revealed three
genotype patterns within the NRIP1 gene that appear to
be over-represented in women affected by endometriosis
(p = 0.006, Fisher exact test). The patterns consist of a
combination of Arg448Gly  together with His221Arg  or
Val1079Phe  variants. We identified three unrelated
women affected by endometriosis carrying double hetero-
zygotes (His221Arg/Arg448Gly  and  Val1079Phe/
Arg448Gly) or homozygote (Arg448Gly/Arg448Gly) geno-
types for these alleles, respectively. The homozygote
(Arg448Gly/Arg448Gly) genotype pattern appeared only in
1 of 94 unselected controls (p = 0.016 Fisher exact test)
and none of 47 super-control women (p = 0.023, Fisher
Exact test), whereas double heterozygotes genotypes did
not appear in any control individual. These results suggest
that specific combinations of amino acid changes at
NRIP1 locus could be related to endometriosis etiology
with a 99.4% of reliability, although given the scarce sam-
ple size the presence of polygenes within NRIP1  locus
must be proven with a larger and independent re-analysis.
Finally, given the preliminary results, we conducted an
small case-control study analyzing all common variants
detected within the NRIP1 locus (Gy75Gly, Arg448Gly and
Ser803Leu). Table 4 shows the results for those test that
Table 2: Anchor and Sensor probes sequences employed for coding Single Nucleotide Polymorphism (cSNP) analysis using 
Fluorescence Resonance Energy Transfer (FRET) technology.
Mutation PROBE SEQUENCE 5' → 3
Gly75Gly 75-ANCHOR AGTAATGGTCCAGTTCTCAATACAC – F
75-SENSOR Cy5 – TACATATCAGGGGTCTGGC – Ph
His221Arg 221-ANCHOR Cy5 – 
AGTGGAACAAAGGTCATGAGTGAAC – Ph
221-SENSOR TCTCCTCATCATGTTGGACA – F
Ile441Val 448-ANCHOR TATTCCAACTGTGTTCCCATAGACT – F
Arg448Gly 448-SENSOR Cy5 – GTCTTGCAAACACCGAACTG – Ph
Ser803Leu 803-ANCHOR GCGCACCTGCCTTACCAGTGTCCCGA – 
F
803-SENSOR Cy5-GACTTTAAATCGGAGCCTGTT – Ph
Val1079Phe 1079-ANCHOR Cy5 – 
CGAGAAACACAAGACAAGGACATTT – Ph
1079-SENSOR GGAGGCAATTCTGTTACCAG – F
Nomenclature: F: Fluoresceine, Ph: Phosphate.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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Detection of germ line variants in NRIP1 in patients with severe endometriosis Figure 1
Detection of germ line variants in NRIP1 in patients with severe endometriosis. A) Spectrofluorimetric analysis of NRIP1 gene 
using real-time PCR. Analysis of the fluorescence measured during melting curve determination in the LightCycler (Roche 
Applied Science). Each allele has a specific melting point and all alleles are represented by its specific nucleotide change with the 
exception of Ile441Val and Arg448Gly polymorphisms. Nt c.512 G->A (Gly75Gly, melting points, Allele G: 62°C; Allele A: 
57°C). Nt c.949 A->G (His221Arg, melting points, Allele A 61°C; Allele G: 56°C). Nt c.1608 A->G (Ile441Val) and Nt c.1629 
C->G (Arg448Gly) (melting points, Allele Val441: 59°C; Allele Gly448: 56°C; wild type: 63°C). Nt c.2695 C->T (Ser803Leu, 
melting points, Allele C: 61°C; Allele T: 55°C). Nt c.3522 G->T (Val1079Phe, melting points, Allele G: 62°C; Allele T: 54°C). B) 
Sequence conservation and location of mutations in the RIP-140 protein. Black shading indicates the position of mutations. 
LXXLL motifs responsible for ligand independent interaction with Retinoid Acid Receptor (RAR) and Retinoid X Receptor 
(RXR) are in bold and underlyned. Signal peptide is depicted in blue, Carboxyl terminal binding protein (CTBP) and RAR inter-
acting motifs are in red and green respectively. Low complexity regions are shown in grey.
Figure 1.
Val1079Phe
Allele T
Allele G
Allele C Allele T
Val1079Phe
S803L SAPALPVSEDFKLEPVSPQDFSFSKNGL
HUMAN SAPALPVSEDFKSEPVSPQDFSFSKNGL
RATTUS SSAALPVSEDLKSEPASPQDFSFSKNGL
MUS STAALPVSEDFKSEPASPQDFSFSKNGL
GALLUS NTAASPASEEMKSEPHSPQDFSFSKNGL
XENOPUS HSFSRSPSEGMKSPNLTPHEFSVSRNGL
Allele G
Allele T
Retinoid acid receptor
interacting motif
V1079F RLTKTNPI--LYYMLQKGG-NSFTSRETQ
HUMAN RLTKTNPI--LYYMLQKGG-NSVTSRETQ
RATTUS RLTKTNPI--LYYMLQKGG-NSVTTQETQ
MUS RLTKTNPI--LYYMLQKGGGNSVTTQETQ
GALLUS RLTKTNPI--LYYMLQKGG-NSVSSQEAH
XENOPUS SSFKSSPHSPSDSLIHKTS-RTESGQINM
Ser803Leu
Wild type
Ile441Arg448
Allele
448Gly
Allele
441Val
CTBP
interacting motif
R448G SSYSNCVPVDLSCKHGTEKSESDQPVS
HUMAN SSYSNCVPIDLSCKHRTEKSESDQPVS
RATTUS SSYSNCVPIDLSCKHRTEKPETERPVS
MUS SSYSNCVPIDLSCKHRIEKPEAERPVS
GALLUS SSHSNCLPIDLSFKQRTDKPDTGPPAS
XENOPUS SSHSNCAPIDLSFKNRVDKPEVLNTAS
AB
H221R DRFAE-SPHRVGQSGTKVMSEPLS
HUMAN DRFAE-SPHHVGQSGTKVMSEPLS
RATTUS DSFVESSPHHVGQSGTKVMSEPLS
MUS DSFVESSHPAVGQSGTKVMSEPLS
GALLUS ERFIE-SPHAV-QSGPKVINEPLS
XENOPUS -KYTE-SSHSGQSSTKGVAAEPIS
Allele A Allele G
Allele A
Allele G
Gly75Gly
His221Arg
MTHGEELGSDVHQDSIVLTYLEGLLMHQAAGGSGTAVDKKSAGHNEEDQNFNISGSAFPT
CQSNGPVLNTHTYQGSGMLHLKKARLLQSSEDWNAAKRKRLSDSIMNLNVKKEALLAGMV
DSVPKGKQDSTLLASLLQSFSSRLQTVALSQQIRQSLKEQGYALSHDSLKVEKDLRCYGV
ASSHLKTLLKKSKVKDQKPDTNLPDVTKNLIRDRFAESPHHVGQSGTKVMSEPLSCAARL
QAVASMVEKRASPATSPKPSVACSQLALLLSSEAHLQQYSREHALKTQNANQAASERLAA
MARLQENGQKDVGSYQLPKGMSSHLNGQARTSSSKLMASKSSATVFQNPMGIIPSSPKNA
GYKNSLERNNIKQAANNSLLLHLLKSQTIPKPMNGHSHSERGSIFEESSTPTTIDEYSDN
NPSFTDDSSGDESSYSNCVPIDLSCKHRTEKSESDQPVSLDNFTQSLLNTWDPKVPDVDI
KEDQDTSKNSKLNSHQKVTLLQLLLGHKNEENVEKNTSPQGVHNDVSKFNTQNYARTSVI
ESPSTNRTTPVSTPPLLTSSKAGSPINLSQHSLVIKWNSPPYVCSTQSEKLTNTASNHSM
DLTKSKDPPGEKPAQNEGAQNSATFSASKLLQNLAQCGMQSSMSVEEQRPSKQLLTGNTD
KPIGMIDRLNSPLLSNKTNAVEENKAFSSQPTGPEPGLSGSEIENLLERRTVLQLLLGNP
NKGKSEKKEKTPLRDESTQEHSERALSEQILMVKIKSEPCDDLQIPNTNVHLSHDAKSAP
FLGMAPAVQRSAPALPVSEDFKSEPVSPQDFSFSKNGLLSRLLRQNQDSYLADDSDRSHR
NNEMALLESKNLCMVPKKRKLYTEPLENPFKKMKNNIVDAANNHSAPEVLYGSLLNQEEL
KFSRNDLEFKYPAGHGSASESEHRSWARESKSFNVLKQLLLSENCVRDLSPHRSNSVADS
KKKGHKNNVTNSKPEFSISSLNGLMYSSTQPSSCMDNRTFSYPGVVKTPVSPTFPEHLGC
AGSRPESGLLNGCSMPSEKGPIKWVITDAEKNEYEKDSPRLTKTNPILYYMLQKGGNSVT
SRETQDKDIWREASSAESVSQVTAKEELLPTAETKASFFNLRSPYNSHMGNNASRPHSAN
GEVYGLLGSVLTIKKESE
Ile441Val/Arg448GlyJournal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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maximize the differences between case and control groups
for each polymorphism. Genotypic distributions of poly-
morphisms analyzed are in accordance with the Hardy-
Weinberg equilibrium law (p > 0.15), indicating no bias
due to technical or stratification problems nor evolution-
dependent genetic sweep/selection events (data not
shown). Interestingly, our analysis revealed that
Arg448Gly polymorphism appears to be weakly associated
with endometriosis in our population (Odds ratio =
2.327, pallele positivity test = 0.027). In contrast, no significant
association could be achieved when comparing unse-
lected versus super-control women, supporting the accu-
racy of the selected control panel (p > 0.34 for Gly75Gly, p
> 0.41 for Arg448Gly, and p > 0.1 for Ser804Leu).
Overall, our results might support the role of NRIP1 gene
in endometriosis, although given the small sample size,
we propose an extensive re-analysis by increasing the sam-
ple size to confirm our results.
Discussion
Endometriosis is a complex disease affecting 10–15% of
women at reproductive age. Very few genes are known to
be altered in this pathology. Molecular genetic analyses
provide some evidence of genetic association in case-con-
trol studies analyzing Estrogen Receptor 1 (ESR1 OMIM
133430) and Cytochrome P450, Family 19, Subfamily A,
Polypeptide 1 (CYP19 OMIM 107910) genes. Interestingly,
both loci are involved in oestrogen mechanism of produc-
tion and action [12,13]. In addition, other nuclear recep-
tor genes, such as Progesterone Receptor (PGR  OMIM
607311) and Peroxisome Proliferative Activated Receptor,
Gamma (PPARG OMIM 601487) gene have been associ-
ated with endometriosis in other case-control studies
[14,15]. The involvement in endometriosis of loci related
to detoxification has been also studied and replicated [16-
18].
Given these preliminary findings and the importance of
steroid receptors in uterine physiology [19] and endome-
triosis pathogenesis [1,20], the biochemical pathways
involved in steroids production, degradation or mecha-
nisms of action appear to be strong candidates for
endometriosis etiology and many other phenotypes
related to human fertility.
Following this working hypothesis, targeting disruption
of nuclear receptors and their regulators such as nrip1 or
CCR4-NOT transcription complex, subunit 7 (cnot7 GenBank
AK009561) in animal models have provided direct evi-
dence of the importance of nuclear receptor homeostasis
in male and female reproduction [3,21-24].
Here we present the first structural analysis of the human
NRIP1 gene in relation to human disease. It is of interest
to mention that the dbSNP includes 26 SNPs for NRIP1
gene currently. Eighteen of these variants are located
within the 3'untranslated region (3'UTR), this genomic
region has not been covered in this study, and the remain-
ing ones are coding SNPs. According to GenBank, only
three SNPs in the 3'UTR region and two coding SNPs have
been validated in population based studies including
Table 3: Summary of DNA variants observed within the coding sequence of the NRIP1 gene.
DNA variant* Amino acid 
Substitution 
(change in 
codon)
dbSNP** 
accession 
number
Detection in 
Endometriotic 
tissue samples 
(40 
chromosomes)
Detection in 
germline DNA 
derived from 
endometriosis 
patients (118 
chromosomes)
Detection in 
controls (282 
chromosomes)
Status
Nt c.512 G->A None [Gly75] 
(ggg to gga)
rs2229741 15/40 57/118 129/282 Common 
polymorphism
Nt c.949 A->G His221Arg 
(cat to cgt)
- 1/40 1/118 3/282 Common 
polymorphism
Nt c.1608 A->G Ile441Val 
(ata to gta)
- 0/20 0/118 4/282 Common 
polymorphism
Nt c.1629 C->G Arg448Gly 
(cga to gga)
rs2229742 9/40 16/118 19/282 Common 
polymorphism
Nt c.2695 C->T Ser803Leu 
(tcg to ttg)
- 2/40 3/118 10/282 Common 
polymorphism
Nt c.3522 G->T Val1079Phe 
(gtt to ttt)
- 1/40 1/118 0/282 Rare Variant/
Mutation
*In accordance with genbank number NM_003489.
** dbSNP: the Single Nucleotide Polymorphism Database at the National Centre for Biotechnology Information (NCBI) http://
www.ncbi.nlm.nih.gov/Journal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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more than 150 chromosomes. The rest of the SNPs are the
result of the bioinformatic alignment of different cDNA
and genomic clones. The allele frequencies here presented
for Gly75Gly (dbSNP rs2229741) and Arg448Gly (dbSNP
rs2229742) polymorphisms are very similar to those
included in dbSNP (data not shown).
Overall, our results are preliminary providingt suggestive,
but not definitive, evidence of NRIP1 gene involvement in
human endometriosis. We think that conclusive proofs of
involvement will be achieved throughout re-analyses of
this study in independent cohorts of patients and con-
trols, rather than performing functional analyses of the
missense mutations observed. The detection of function-
ality of DNA variants involved in complex traits such
endometriosis, is near to be impossible using conven-
tional technologies because the effect from single genetic
variant/mutation is expected to be very small and it is only
the joint effect of several susceptibility genes that leads to
the disease [25]. In this sense, we are currently recruiting
a higher number of patients and controls to perform a
proper re-analysis of our results.
Regarding Arg448Gly polymorphism, we propose that the
variant could act as a low penetrance allele related to
human endometriosis. The molecular mechanism of this
mutation is not well understood, although its location
and degree of conservation provide some interesting
clues. In fact, Arg448 residue of RIP140 protein is com-
pletely conserved among humans, rats, mice, gallus and
xenopus (Fig. 1b). Moreover, the non-conservative substi-
tution detected (Arg448Gly) might affect the Carboxyl ter-
minal binding protein (CTBP) interacting motif of
RIP140 protein that is located close to this amino acid res-
idue (Fig. 1b).
On the basis of genotype analysis in affected women, we
propose that Arg448Gly  mutation could act in concert
with other genetic variants within NRIP1 or other loci. In
this way, we found a single woman affected by endome-
triosis simultaneously carrying Val1079Phe mutation and
Arg448Gly polymorphism both in a heterozygous state.
Val1079Phe also arises in an inter-specific conserved resi-
due. Moreover, this mutation is located close to (and may
disrupt) the retinoid acid receptor interacting motif
"LTKTNPILYYMLQK" of RIP140 protein (Fig. 1b). Sup-
porting its involvement in the disease, we have not iden-
tified the Val1079Phe  mutation in 282-control
chromosomes. Intriguingly, retinoid acid receptors alpha,
gamma 2 and its regulator cnot7 have been involved in
male sterility [24,26,27]. Moreover, the presence of multi-
ple specific functional rare variants in affected patients
have been recently proposed and evaluated [28]. This
hypothesis is an alternative to explain the genetic compo-
nent of complex traits in front of the widely accepted com-
mon disease common variant hypothesis [29].
Finally, we identified a single patient carrying a unique
genotype combination comprising His221Arg rare variant
and, again, Arg448Gly  polymorphism. The absence of
inter-specific amino acidic conservation and the inexist-
ence of known functional domains close to His221Arg
variant do not support the functionality of His221Arg
allele. However, His221Arg only appears combined with
Arg448Gly in a woman affected by endometriosis. This
combination never appears in 141 unrelated controls.
Table 4: Association studies of common DNA variants of the NRIP1 gene in relation to human endometriosis.
NRIP1 
polymorphism 
(change in codon)
Genotypes Patients 
(n = 59)
Unselected 
Controls
(n = 94)
Super Controls 
(n = 47)
All Controls
(n = 141)
Statistical 
Analysis*
Gly75Gly (ggg to gga) aa 15 19 9 28 P = 0.34 
(Heterozygous 
test)
ag 27 46 27 73
gg 17 28 11 39
Arg448Gly (cga to gga) cc 44 83 40 123 P = 0.027 (Allele 
positivity test)
cg 14 10 7 17
g g 1101
Ser803Leu (tcg to ttg) cc 56 85 46 130 P = 0.59 
(Armitage's trend 
test)
ct 3 9 1 10
t t 0000
*Compares patients versus merged controls. Best p value employing tests for genetic association according to Sasieni (1997). Ile441Val and 
His221Arg are not analyzed due to small or null sample size in endometriosis samples.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:11 http://www.jexpclinassistreprod.com/content/2/1/11
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Functional assays or large cohorts analyses will help to
elucidate its involvement in this pathology.
Our results support that NRIP1 gene might contain alleles
related to endometriosis in humans. NRIP1 gene encodes
a highly pleiotropic nuclear receptor co-regulator
(RIP140) [30]. This protein interacts and regulates multi-
ple members of the nuclear receptor super-family. Some
of them have been associated with endometriosis. The
wide repertoire of RIP140 targets might explain the com-
plex pathological findings observed in human endometri-
osis. In fact, a recent report revealed a complex
mechanism, involved in endometriosis and other oestro-
gen-related traits, by which ER-mediated oestrogen signal-
ing is modulated by a co-regulatory-like function of
activated AhR/Arnt dioxin receptor complex, giving rise to
adverse oestrogen-related actions of dioxin-type environ-
mental contaminants [31]. Intriguingly, oestrogen and
dioxin nuclear receptor pathways are modulated by
RIP140 protein [32,33].
According to previous data, mouse models reports and the
present results, NRIP1 gene appears to be an attractive
gene for human endometriosis etiology and other related
pathologies. In addition, we have found a genetic interac-
tion of NRIP1 gene with Estrogen receptor alpha and beta
(ESR1 and ESR2) genes in two estrogen-dependent dis-
eases such as male infertility [34] and osteoporosis (man-
uscript in preparation). For these reasons, further
evaluation of NRIP1 gene in many oestrogen-related phe-
notypes is warranted.
Conclusion
Our results suggest that NRIP1 gene variants, separately or
in combinations, might act as predisposing factors for
human endometriosis. According to previous data, mouse
models reports and the present results, NRIP1 appears to
be an attractive candidate gene for human endometriosis
etiology and other estrogen-related pathologies.
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